Abstract
The effects of the monoclonal antibody-mitomycin C conjugate against human colon cancers were studied,in vitro andin vivo. Mitomycin C (MMC) was conjugated with the human colon cancer-specific monoclonal antibody, using a cyanogen bromide method. The effect of the conjugate and free MMC,in vitro, was measured by incubation with human colon cancer SW1116 cells, The MMC concentration of the conjugate and of free MMC needed for 50 per cent killing of target cells was 0.11 μg/ml and 7.00 μg/ml, respectively. The effect of the conjugate and of free MMC,in vivo, was assayed by the growth inhibition of human colon cancer xenografted in nude mice, after intraperitoneal injections of 30 μg MMC/kg. Antitumor effects of the conjugate against the cancer in nude mice were significantly more potent than that of free MMC.
This is a preview of subscription content, log in via an institution to check access.
References
Philips FS, Schwartz HS, Sternberg SS. Pharmacology of mitomycin C. I. Toxicity and pathologic effects. Cancer Res 1960; 20: 1354–1361.
Godfrey TE, Wilbur DW. Clinical experience with mitomycin C in large infrequent doses. Cancer 1972; 29: 1647–1652.
Kotanagi H. Production and analysis of monoclonal antibodies against human colorectal cancers. Akita J Med 1985; 11: 221–236. (in Japanese)
Takahashi M, Tanaka J, Kotanagi H, Fukuda K, Ogata N, Masuda T, Takahashi T, Yamaguchi Y, Hashimoto Y, Masuko T.In vivo localization of monoclonal antibody A7 to human colon cancer inoculated into nude mice. Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol) 1985; 82: 1607. (in Japanese)
Suzuki T, Sato E, Goto K, Katsurada Y, Unno K, Takahashi T. The preparation of mitomycin C, adriamycin and daunomycin covalently bound to antibodies as improved cancer chemotherapeutic agents. Chem Pharm Bull 1981; 29: 844–848.
Ovejera AA, Houchens DP, Barker AD. Chemotherapy of human tumor xenografts in genetically athymic mice. Ann Clinic Laborat Sci 1978; 8: 50–56.
Blythman HE, Casellas P, Gros O, Gros P, Jansen FK, Paolucci F, Pau B, Vidal H. Immunotoxines: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature 1981; 290: 145–146.
Raso V, Ritz J, Basala M, Schlossman SF. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. Cancer Res 1982; 42: 457–464.
Hashimoto Y, Sugawara M, Masuko T, Hojo H. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody. Cancer Res 1983; 43: 5328–5334.
Kojima T, Hashida M, Muranishi S, Sezaki H. Anti-tumor activity of timed release of a derivative of mitomycin C, agarose bead conjugate. Chem Pharm Bull 1978; 26: 1818–1824.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kotanagi, H., Fukuda, K., Ogata, N. et al. Potent effects of the monoclonal antibody-mitomycin C conjugate on human colon cancers. The Japanese Journal of Surgery 17, 47–50 (1987). https://doi.org/10.1007/BF02470585
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470585